Human platelet‐rich plasma induces chondrogenic differentiation of subchondral progenitor cells in polyglycolic acid–hyaluronan scaffolds
Source abstract
Abstract
Abstract Cartilage repair approaches may be improved by addition of human platelet‐rich plasma (PRP) that increases chondrogenic differentiation of mesenchymal stem and progenitor cells. The aim of our study was to evaluate the effect of human PRP on the differentiation of multipotent human subchondral progenitor cells in resorbable polyglycolic acid–hyaluronan (PGA‐HA) scaffolds. PGA‐HA scaffolds were loaded with subchondral progenitor cells and stimulated with transforming growth factor‐beta3 (TGFB3) or 5% PRP, whereas nonstimulated cultures served as controls. Chondrogenic differentiation was evaluated by real‐time gene expression analysis of typical chondrogenic marker genes and by immunohistochemical staining of extracellular cartilage matrix molecules such as proteoglycans and collagen type II. TGFB3 and PRP induced the expression of chondrogenic marker genes collagen type II and IX, aggrecan, and cartilage oligomeric matrix protein in subchondral progenitor cells cultured in PGA‐HA scaffolds compared with nonstimulated controls. Progenitor cells in PGA‐HA scaffolds formed an extracellular matrix rich in proteoglycans and collagen type II on treatment with PRP, but to a lesser extent, than in cultures stimulated with TGFB3. The results suggest that PRP induces chondrogenic differentiation of progenitor cells in PGA‐HA scaffolds and may be therefore beneficial in scaffold‐assisted cartilage repair approaches involving stem and progenitor cells. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 681–692, 2014.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Osteoarthritis Treatment and Mechanisms · Knee injuries and reconstruction techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
TransTissue Technologies GmbH Charitéplatz 1 10117 Berlin Germany
Tissue Engineering Laboratory Department of Rheumatology and Clinical Immunology Charité‐Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Tumor Medicine Department of Transfusion Medicine Charité‐Universitätsmedizin Berlin Charitéplatz 1 10117 Berlin Germany
Struttura Complessa di Ortopedia e Traumatologia, Ospedale degli Infermi di Biella ASLBI Biella Italy
References (38)
Show source-provided references
1. 10.1053/jars.2003.5011210.1053/jars.2003.50112 ↗
2. The microfracture technic in the management of complete cartilage defects in the knee joint10.1007/PL00003545 ↗
3. 10.1002/jor.2063510.1002/jor.20635 ↗
4. 10.1186/1749-799X-7-1010.1186/1749-799X-7-10 ↗
5. 10.2106/00004623-200403000-0000110.2106/00004623-200403000-00001 ↗
6. 10.1016/j.arthro.2005.06.01810.1016/j.arthro.2005.06.018 ↗
7. 10.1097/00003086-200302000-0003110.1097/00003086-200302000-00031 ↗
8. 10.1016/j.joca.2012.06.01610.1016/j.joca.2012.06.016 ↗
9. 10.1002/jor.2087910.1002/jor.20879 ↗
10. 10.1186/1749-799X-7-3710.1186/1749-799X-7-37 ↗
11. 10.1016/j.arthro.2009.04.07710.1016/j.arthro.2009.04.077 ↗
12. 10.1302/0301-620X.92B8.2434110.1302/0301-620X.92B8.24341 ↗
13. 10.1007/s11999-011-2107-410.1007/s11999-011-2107-4 ↗
14. 10.3109/0300820090311190610.3109/03008200903111906 ↗
15. 10.1002/jor.2200510.1002/jor.22005 ↗
16. 10.1097/00008505-200110000-0000210.1097/00008505-200110000-00002 ↗
17. 10.1302/0301-620X.91B8.2254610.1302/0301-620X.91B8.22546 ↗
18. 10.1007/s00167-009-0940-810.1007/s00167-009-0940-8 ↗
19. 10.1007/s00167‐013‐2484‐110.1007/s00167‐013‐2484‐1 ↗
20. 10.1054/jcms.2002.028510.1054/jcms.2002.0285 ↗
21. 10.1136/jcp.51.7.50610.1136/jcp.51.7.506 ↗
22. A reagent for the single‐step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
23. 10.1016/0268-960X(93)90024-X10.1016/0268-960X(93)90024-X ↗
24. Is platelet‐rich plasma the perfect enhancement factor? A current review
25. 10.1111/j.1524-475X.2007.00259.x10.1111/j.1524-475X.2007.00259.x ↗
26. 10.1007/s11999-011-1857-310.1007/s11999-011-1857-3 ↗
27. 10.1089/ten.tea.2011.008310.1089/ten.tea.2011.0083 ↗
28. 10.1016/S0736-0266(02)00018-910.1016/S0736-0266(02)00018-9 ↗
29. 10.1634/stemcells.21-6-68110.1634/stemcells.21-6-681 ↗
30. 10.1016/j.biomaterials.2007.09.00510.1016/j.biomaterials.2007.09.005 ↗
31. 10.1002/jor.2126310.1002/jor.21263 ↗
32. 10.1006/excr.1997.385810.1006/excr.1997.3858 ↗
33. 10.1006/excr.2001.527810.1006/excr.2001.5278 ↗
34. 10.1089/ten.2006.12.306710.1089/ten.2006.12.3067 ↗
35. 10.2106/00004623-199812000-0000410.2106/00004623-199812000-00004 ↗
36. 10.1016/j.bbrc.2008.05.18310.1016/j.bbrc.2008.05.183 ↗
37. 10.1007/s00441-004-1075-310.1007/s00441-004-1075-3 ↗
38. 10.1016/j.arthro.2011.10.01810.1016/j.arthro.2011.10.018 ↗